Axelar AB

Axelar AB is a Swedish biotechnology company founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson, and Karolinska Innovations AB / Karolinska Development AB. The company focuses its research and other activities on insulin-like growth factor-1 (IGF-1) receptor inhibitors and their application in significant human diseases, particularly cancer. Axelar AB is located at the Karolinska Institutet Science Park in Stockholm, Sweden.